Lichen International Limited filed a Form 6-K on November 10, 2026, reporting that shareholders approved all three proposals at an extraordinary general meeting held on November 9, 2026, including a 100-for-1 share consolidation set to take effect on November 19, 2026.

Key Highlights

  • Share consolidation approved: Every 100 Class A or Class B Ordinary Shares of par value US$0.008 each will be consolidated into one share of par value US$0.80 each, effective November 19, 2026.
  • Authorized share capital restructured: The authorized capital will change from 20,000,000,000 Class A and 5,000,000,000 Class B shares to 200,000,000 series A and 50,000,000 series B shares, with total authorized capital remaining at US$200,000,000.
  • Quorum and voting power: A total of 12,029,745 voting power, representing 69.47% of total voting power as of the October 21, 2026 record date, was present in person or by proxy.
  • Proposal One vote: The share consolidation resolution received 12,014,239 votes for, 15,500 against, and 6 withheld or abstained.
  • Amended articles adopted: Shareholders also approved an amended and restated memorandum and articles of association to reflect the share consolidation, effective November 19, 2026.
  • Fractional shares: Any fractional shares resulting from the consolidation will be rounded up to the nearest whole ordinary share, according to the filing.

Lichen International Shareholders Approve 100-for-1 Consolidation at November 9 EGM

According to the Form 6-K filed with the SEC on November 10, 2026, Lichen International Limited (NASDAQ:LICN) held an extraordinary general meeting on November 9, 2026, at 10:00 p.m. Beijing Time (9:00 a.m. Eastern Time) at its principal offices at 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013. The company disclosed that shareholders present or represented by proxy held 10,929,745 Class A Ordinary Shares, each carrying one vote per share, and 110,000 Class B Ordinary Shares, each carrying ten votes per share, for a combined voting power of 12,029,745.

The filing states that all three proposals submitted to the meeting were approved. Proposal One, the share consolidation, passed with 12,014,239 votes in favor, 15,500 against, and 6 withheld or abstained. Under the approved consolidation, every 100 existing Class A Ordinary Shares of par value US$0.008 will become one series A ordinary share of par value US$0.80, and every 100 Class B Ordinary Shares of par value US$0.008 will become one series B ordinary share of par value US$0.80. The total authorized share capital of US$200,000,000 remains unchanged, but the number of authorized shares is reduced from 25,000,000,000 total to 250,000,000 total.

Proposal Two, adopting the amended and restated memorandum and articles of association to reflect the consolidation, received 12,014,287 votes for and 15,458 against, with zero abstentions. Proposal Three, an adjournment provision included as a contingency, was approved with 12,014,758 votes for and 14,987 against. The filing was signed by Ya Li, identified as Chief Executive Officer, Chairman of the Board, and Director.

What Was Disclosed

Lichen International Limited reported the results of a November 9, 2026 extraordinary general meeting at which shareholders approved a 100-for-1 share consolidation effective November 19, 2026, an amended memorandum and articles of association, and an adjournment contingency resolution.